Skip to content

Erector Spina Plane Block vs Serratus Anterior Plane Block for Postoperative Mastectomy Pain

Comparison of Erector Spina Plane Block and Serratus Anterior Plane Block in Patients Undergoing Mastectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04296188
Enrollment
60
Registered
2020-03-05
Start date
2020-03-18
Completion date
2021-03-15
Last updated
2020-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastectomy, Pain, Postoperative, Recovery Period, Anesthesia

Keywords

Pain Management, Quality of Healthcare

Brief summary

The aim of this study is to compare the efficiency of serratus anterior plane block and erector spina plane block on analgesic consumption, postoperative pain and patient's satisfaction and recovery quality in patients undergoing mastectomy.

Detailed description

Mastectomy may cause severe postoperative pain. There are several analgesic methods for postoperative pain management. Serratus anterior plane (SAP) block is an interfascial plane block which is performed into the fascial plane of serratus anterior muscle. It provides effective analgesia in anterior, posterior and lateral dermatomes of thorax. There are several studies about its analgesic efficacy for mastectomy pain. The erector spina plane (ESP) block is another novel plan block which provides analgesia at multi-dermatomal area of the anterior, posterior, and lateral thoracic and abdominal walls. There are some studies about its effectiveness for postoperative mastectomy pain management. However, according to our best knowledge, there is no literature comparing the efficacy of ESP block and SAP block patients undergoing mastectomy.

Interventions

PROCEDUREserratus anterior plane block

ultrasound guided serratus anterior plane block will be done with % 0.25 bupivacaine.

ultrasound guided erector spina plane block will be done with % 0.25 bupivacaine.

Sponsors

Tokat Gaziosmanpasa University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American society of score anesthesiologist I-II-III * Elective modified radical mastectomy * 18-65 years old

Exclusion criteria

* neurological disease * coagulopathy disease or using anticoagulants * non-cooperative * allergic to one of the drugs used in the study * recurrent breast cancer * body mass index is above 35

Design outcomes

Primary

MeasureTime frameDescription
Analgesic consumptionFrom at the end of surgery (at postoperative 0th hour) to postoperative 24th hoursTramadol dose will be calculated as milligram

Secondary

MeasureTime frameDescription
Postoperative pain intensityAt 0,2,4,6,12,24th hours after surgeryNumeric rating scale which is 0 to 10 will be recorded.In this scale, 0 is no pain, 10 is the worst pain.
Quality of recoveryAt postoperative 24th hoursQuality of recovery (QoR-40) questionaire will be recorded. The QoR-40 is a questionaire which measures of five dimensions of health: patient support, comfort, emotions, physical independence, and pain on a five-point likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery)
The number of patients with perioperative side effectsFrom 30 minute before surgery to postoperative 24th hoursThe number of patients with perioperative side effects(emesis, nausea, local anesthetic toxicity, pneumothorax, local hematoma) will be recorded

Contacts

Primary Contactmehtap gürler balta, MD
drmehtapgurler@hotmail.com+903562129500
Backup Contacttuğba karaman, MD
drtugbaguler@hotmail.com+903562129500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026